|
1.
|
Bae YS, Oh H, Rhee SG and Yoo YD:
Regulation of reactive oxygen species generation in cell signaling.
Mol Cells. 32:491–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Bergamini CM, Gambetti S, Dondi A and
Cervellati C: Oxygen, reactive oxygen species and tissue damage.
Curr Pharm Des. 10:1611–1626. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Hiraishi H, Terano A, Razandi M, Sugimoto
T, Harada T and Ivey KJ: Role of cellular superoxide dismutase
against reactive oxygen metabolite injury in cultured bovine aortic
endothelial cells. J Biol Chem. 267:14812–14817. 1992.
|
|
4.
|
Fiser B, Szori M, Jojart B, Izsak R,
Csizmadia IG and Viskolcz B: Antioxidant potential of glutathione:
a theoretical study. J Phys Chem B. 115:11269–11277. 2011.
View Article : Google Scholar
|
|
5.
|
Habib GM: Arsenite causes down-regulation
of Akt and c-Fos, cell cycle dysfunction and apoptosis in
glutathione-deficient cells. J Cell Biochem. 110:363–371.
2010.PubMed/NCBI
|
|
6.
|
Kim SJ, Jung HJ and Lim CJ: Disruption of
redox homeostasis and induction of apoptosis by suppression of
glutathione synthetase expression in a mammalian cell line. Free
Radic Res. 45:1040–1051. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Collet JF and Messens J: Structure,
function, and mechanism of thioredoxin proteins. Antioxid Redox
Signal. 13:1205–1216. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lu J and Holmgren A: Thioredoxin system in
cell death progression. Antioxid Redox Signal. 17:1738–1747. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Noike T, Miwa S, Soeda J, Kobayashi A and
Miyagawa S: Increased expression of thioredoxin-1, vascular
endothelial growth factor, and redox factor-1 is associated with
poor prognosis in patients with liver metastasis from colorectal
cancer. Hum Pathol. 39:201–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Karlenius TC, Shah F, Di Trapani G, Clarke
FM and Tonissen KF: Cycling hypoxia up-regulates thioredoxin levels
in human MDA-MB-231 breast cancer cells. Biochem Biophys Res
Commun. 419:350–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Li C, Thompson MA, Tamayo AT, et al:
Over-expression of Thioredoxin-1 mediates growth, survival, and
chemoresistance and is a druggable target in diffuse large B-cell
lymphoma. Oncotarget. 3:314–326. 2012.PubMed/NCBI
|
|
12.
|
Icardi L, De Bosscher K and Tavernier J:
The HAT/HDAC interplay: multilevel control of STAT signaling.
Cytokine Growth Factor Rev. 23:283–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lu Z, Luo RZ, Peng H, et al: E2F-HDAC
complexes negatively regulate the tumor suppressor gene ARHI in
breast cancer. Oncogene. 25:230–239. 2006.PubMed/NCBI
|
|
14.
|
Lehmann A, Denkert C, Budczies J, et al:
High class I HDAC activity and expression are associated with
RelA/p65 activation in pancreatic cancer in vitro and in vivo. BMC
Cancer. 9:3952009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wang L, Zou X, Berger AD, et al: Increased
expression of histone deacetylaces (HDACs) and inhibition of
prostate cancer growth and invasion by HDAC inhibitor SAHA. Am J
Transl Res. 1:62–71. 2009.PubMed/NCBI
|
|
16.
|
Shankar S and Srivastava RK: Histone
deacetylase inhibitors: mechanisms and clinical significance in
cancer: HDAC inhibitor-induced apoptosis. Adv Exp Med Biol.
615:261–298. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Chen MY, Liao WS, Lu Z, et al: Decitabine
and suberoylanilide hydroxamic acid (SAHA) inhibit growth of
ovarian cancer cell lines and xenografts while inducing expression
of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and
autophagy. Cancer. 117:4424–4438. 2011. View Article : Google Scholar
|
|
18.
|
An Z, Gluck CB, Choy ML and Kaufman LJ:
Suberoylanilide hydroxamic acid limits migration and invasion of
glioma cells in two and three dimensional culture. Cancer Lett.
292:215–227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Butler LM, Zhou X, Xu WS, et al: The
histone deacetylase inhibitor SAHA arrests cancer cell growth,
up-regulates thioredoxin-binding protein-2, and down-regulates
thioredoxin. Proc Natl Acad Sci USA. 99:11700–11705. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Ungerstedt J, Du Y, Zhang H, Nair D and
Holmgren A: In vivo redox state of human thioredoxin and redox
shift by the histone deacetylase inhibitor suberoylanilide
hydroxamic acid (SAHA). Free Radic Biol Med. 53:2002–2007. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Duenas-Gonzalez A, Lizano M, Candelaria M,
Cetina L, Arce C and Cervera E: Epigenetics of cervical cancer. An
overview and therapeutic perspectives. Mol Cancer. 4:382005.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Huang BH, Laban M, Leung CH, et al:
Inhibition of histone deacetylase 2 increases apoptosis and
p21Cip1/WAF1 expression, independent of histone
deacetylase 1. Cell Death Differ. 12:395–404. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Hedley D, Pintilie M, Woo J, et al:
Up-regulation of the redox mediators thioredoxin and
apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions
of invasive cervical carcinomas, mapped using multispectral,
wide-field fluorescence image analysis. Am J Pathol. 164:557–565.
2004. View Article : Google Scholar
|
|
24.
|
Cooper AL, Greenberg VL, Lancaster PS, van
Nagell JR Jr, Zimmer SG and Modesitt SC: In vitro and in vivo
histone deacetylase inhibitor therapy with suberoylanilide
hydroxamic acid (SAHA) and paclitaxel in ovarian cancer. Gynecol
Oncol. 104:596–601. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Han YH, Moon HJ, You BR, Kim SZ, Kim SH
and Park WH: Effects of carbonyl cyanide p-(trifluoromethoxy)
phenylhydrazone on the growth inhibition in human pulmonary
adenocarcinoma Calu-6 cells. Toxicology. 265:101–107. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Han YH, Moon HJ, You BR and Park WH: The
effect of MG132, a proteasome inhibitor on HeLa cells in relation
to cell growth, reactive oxygen species and GSH. Oncol Rep.
22:215–221. 2009.PubMed/NCBI
|
|
27.
|
You BR and Park WH: Proteasome inhibition
by MG132 induces growth inhibition and death of human pulmonary
fibroblast cells in a caspase-independent manner. Oncol Rep.
25:1705–1712. 2011.PubMed/NCBI
|
|
28.
|
You BR and Park WH: Zebularine inhibits
the growth of HeLa cervical cancer cells via cell cycle arrest and
caspase-dependent apoptosis. Mol Biol Rep. 39:9723–9731. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Han YH, Kim SH, Kim SZ and Park WH:
Carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) as an
O2(*−) generator induces apoptosis via the
depletion of intracellular GSH contents in Calu-6 cells. Lung
Cancer. 63:201–209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Han YH and Park WH: Propyl gallate
inhibits the growth of HeLa cells via regulating intracellular GSH
level. Food Chem Toxicol. 47:2531–2538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Elbashir SM, Harborth J, Lendeckel W,
Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs
mediate RNA interference in cultured mammalian cells. Nature.
411:494–498. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
You BR and Park WH: Arsenic trioxide
induces human pulmonary fibroblast cell death via increasing ROS
levels and GSH depletion. Oncol Rep. 28:749–757. 2012.PubMed/NCBI
|
|
33.
|
You BR and Park WH: Suberoyl bishydroxamic
acid-induced apoptosis in HeLa cells via ROS-independent,
GSH-dependent manner. Mol Biol Rep. 40:3807–3816. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Lauricella M, Ciraolo A, Carlisi D, Vento
R and Tesoriere G: SAHA/TRAIL combination induces detachment and
anoikis of MDA-MB231 and MCF-7 breast cancer cells. Biochimie.
94:287–299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Carlisi D, Lauricella M, D’Anneo A, et al:
The histone deacetylase inhibitor suberoylanilide hydroxamic acid
sensitises human hepatocellular carcinoma cells to TRAIL-induced
apoptosis by TRAIL-DISC activation. Eur J Cancer. 45:2425–2438.
2009. View Article : Google Scholar
|
|
36.
|
Al-Yacoub N, Fecker LF, Mobs M, et al:
Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is
related to down-regulation of c-FLIP and enhanced TRAIL signaling.
J Invest Dermatol. 132:2263–2274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Eot-Houllier G, Fulcrand G,
Magnaghi-Jaulin L and Jaulin C: Histone deacetylase inhibitors and
genomic instability. Cancer Lett. 274:169–176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Ungerstedt JS, Sowa Y, Xu WS, et al: Role
of thioredoxin in the response of normal and transformed cells to
histone deacetylase inhibitors. Proc Natl Acad Sci USA.
102:673–678. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Han YH, Kim SZ, Kim SH and Park WH:
Intracellular GSH level is a factor in As4.1 juxtaglomerular cell
death by arsenic trioxide. J Cell Biochem. 104:995–1009. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Han YH, Kim SZ, Kim SH and Park WH:
Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by
diethyldithiocarbamate or buthionine sulfoximine. Int J Oncol.
33:205–213. 2008.PubMed/NCBI
|
|
42.
|
Han YH, Kim SZ, Kim SH and Park WH:
Suppression of arsenic trioxide-induced apoptosis in HeLa cells by
N-acetylcysteine. Mol Cells. 26:18–25. 2008.PubMed/NCBI
|
|
43.
|
Estrela JM, Ortega A and Obrador E:
Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci.
43:143–181. 2006. View Article : Google Scholar
|
|
44.
|
Tian C, Gao P, Zheng Y, et al: Redox
status of thioredoxin-1 (TRX1) determines the sensitivity of human
liver carcinoma cells (HepG2) to arsenic trioxide-induced cell
death. Cell Res. 18:458–471. 2008. View Article : Google Scholar : PubMed/NCBI
|
